Phase
Condition
Colon Cancer Screening
Treatment
Magnetic Flexible Endoscope (MFE)
Clinical Study ID
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female, 18 to 70 years of age.
Able to provide written informed consent.
ASA class < 3
No significant medical problems
Abdominal circumference < 96 cm
Exclusion
Exclusion Criteria:
Patients who do not meet inclusion criteria
Patients who are unable or unwilling to provide informed consent
Magnetic implants and wearable devices (such as insulin pumps)
Patients who are pregnant. As part of routine pre-operative care, all patients withuterus who are of childbearing potential will undergo either urine or bloodpregnancy testing
Cancer positive subjects or any patients currently undergoing any treatment ortherapy to treat, cure, or mitigate cancer
Symptoms consistent with coronavirus (COVID-19) --- pyrexia, new persistent cough oranosmia --- or a positive coronavirus (COVID-19) PCR swab result
Previous failed colonoscopy
Colonic resection
Severe diverticulosis
Known or suspected colonic stricture
Previous radiation therapy to the abdomen or pelvis
Any active inflammatory bowel condition (e.g. active IBD or diverticulitis)
Known or suspected bowel obstruction
Presence of ascites
Participants taking anticoagulant medications or antiplatelet therapy (excludingaspirin) within the last 7 days
Known coagulation disorder (INR ≥ 1.5 or platelets < 150 x 10^9)
Known to have phenylketonuria or G6PD deficiency
Abdominal surgery within the last 6 months
Drug or alcohol abuse
Study Design
Study Description
Connect with a study center
Vanderbilt University Medical Center
Nashville, Tennessee 37232
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.